PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Olive leaf extract (500 mg twice daily) was evaluated for its anti-hypertensive and hypolipidemic effects in comparison with Captopril [PMID:21036583].
Supplementation with 250 mg/day of OLE for 12 weeks significantly improved overall MENQoL scores and bone mineral density in the right arm compared to placebo [PMID:39599665].
A pilot randomized controlled trial found no statistically significant time-group interaction for the change in HbA1c after 24 weeks of OLE capsules [PMID:39818111].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 31901903 (2020) — Olive Leaf (Olea europaea L. folium): Potential Effects on Glycemia and Lipidemia. · Annals of nutrition & metabolism
- 2.PMID: 35614890 (2022) — Olea europaea L. (olive) leaf extract ameliorates learning and memory deficits in streptozotocin-induced diabetic rats. · Avicenna journal of phytomedicine
- 3.PMID: 25726243 (2014) — Polyphenols benefits of olive leaf (Olea europaea L) to human health. · Nutricion hospitalaria
- 4.PMID: 39818111 (2025) — Efficacy and safety of olive leaf extract (Olea europaea L.) for glycaemic control in adults with type 2 diabetes mellitus (ESOLED): A pilot randomised controlled trial. · Complementary therapies in clinical practice
- 5.PMID: 36181589 (2023)